Cargando…
Diabetes has no additional impact on retinal ganglion cell loss in a mouse model of spontaneous glaucoma
PURPOSE: There is no valid medical treatment for diabetic retinopathy mostly because its pathogenesis remains largely unknown. Early stages of diabetic retinopathy, just like glaucoma, are characterized by the loss of retinal ganglion cells. Whether the two diseases may share a similar pathogenic ba...
Autores principales: | Maestroni, Silvia, Belvedere, Arianna, Viganò, Ilaria, Meoni, Cesare, Di Matteo, Federico, Gabellini, Daniela, Bandello, Francesco, Pierro, Luisa, Zerbini, Gianpaolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152559/ https://www.ncbi.nlm.nih.gov/pubmed/36523153 http://dx.doi.org/10.1177/11206721221145980 |
Ejemplares similares
-
Progressive Thinning of Retinal Nerve Fiber Layer/Ganglion Cell Layer (RNFL/GCL) as Biomarker and Pharmacological Target of Diabetic Retinopathy
por: Zerbini, Gianpaolo, et al.
Publicado: (2023) -
Topical nerve growth factor prevents neurodegenerative and vascular stages of diabetic retinopathy
por: Zerbini, Gianpaolo, et al.
Publicado: (2022) -
The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment
por: Tremolada, Gemma, et al.
Publicado: (2012) -
Intrinsically photosensitive retinal ganglion cells in glaucoma
por: Gao, Jingyi, et al.
Publicado: (2022) -
Imaging of retinal ganglion cells in glaucoma: pitfalls and challenges
por: Werkmeister, R. M., et al.
Publicado: (2013)